<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000588694"><TermName>tositumomab and iodine I 131 tositumomab</TermName><TermPronunciation>(TAH-sih-TOO-moh-mab ... I-oh-dine I 131 TAH-sih-TOO-moh-mab)</TermPronunciation><TermDefinition><DefinitionText>A combination of drugs used to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Tositumomab and iodine I 131 tositumomab is made up of a monoclonal antibody called tositumomab and a form of tositumomab that is linked to a radioactive substance called iodine I 131. It is a type of radioimmunoconjugate. Also called Bexxar and Bexxar regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720800" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tositumomab and iodine I 131 tositumomab&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720801" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tositumomab y tositumomab con yodo 131&quot;" language="es" id="_4"/><SpanishTermName>tositumomab y tositumomab con yodo 131</SpanishTermName><SpanishTermDefinition><DefinitionText>Combinación de medicamentos que se usa para tratar ciertos tipos de linfomas no Hodgkin de células B.  También está en estudio para el tratamiento de otros tipos de cáncer. El régimen de tositumomab y tositumomab con yodo I 131 está elaborado con un anticuerpo monoclonal que se llama tositumomab y una forma de tositumomab que se enlaza a una sustancia radiactiva que se llama yodo 131. Es un tipo de radioinmunoconjugado.    También se llama Bexxar y régimen de Bexxar.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-02-26</DateFirstPublished><DateLastModified>2011-03-03</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000585474">Tositumomab and Iodine I 131 Tositumomab</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
